You are here
Professor Angela Morgan
Professor Angela Morgan is Lead of the Neuroscience of Speech group at Murdoch Childrens Research Institute. Angela is a Speech Pathologist and NHMRC Practitioner Fellow. Angela has expertise in speech and language phenotyping.
Angela's research is published in well-respected cross-disciplinary journals including the British Medical Journal, Brain, Neurology, and Neuroscience and Biobehavioural Reviews. She also publishes in discipline specific journals to ensure her translational clinical work reaches the appropriate audience. Angela receives regular international keynote speaker invitations in countries such as the USA and Germany.
- 2015, National Health and Medical Research Council Practitioner Fellowship
- 2015, German Humboldt Foundation Experienced Research Fellowship
- 2013, Murdoch Childrens Research Early to Mid Career Researcher Award
- 2013, Australian Academy of Science Theo Murphy Travel Award
- 2012, Elizabeth Usher Speech Pathology Australia Award and Keynote presentation (peer recognition of original research contribution to the field)
- 2010, Victorian Young Tall Poppy Award, Australian Institute of Policy and Science, (awarded to 9 early career scientists in Victoria for early career research success)
- 2010, National Health and Medical Research Council Achievement Award
- 2009, National Health and Medical Research Council Career Development Award
- 2008, Australian Academy of Science Theo Murphy Travel Award
- 2008, Harold Mitchell International Travelling Fellowship
*Significant career breaks 2010, 2013
Angela currently leads a 5 year NHMRC Centre of Research Excellence on Speech and Language Neurobiology, which runs until the end of 2021. This NHMRC CRE is a partnership between the Murdoch Childrens Research Institute, University of Melbourne, Walter and Eliza Hall Institutes, Florey Neuroscience Institute, University College London, Griffith University and the Max Planck Institute for Psycholinguistics in Nijmegen. This exciting cross-disciplinary Centre encompasses collaborations with neurologists, speech pathologists, paediatricians, neuroscientists, neuropsychologists, paediatric dentists, linguists, bioinformaticians, clinical and molecular geneticists, MR physicists and neuroimaging experts. The research involves core collaborators in the UK, Netherlands, Germany and the US. The CRE has a core focus on cross-disciplinary training of the next generation of researchers dedicated to unravelling the aetiology of child speech and language disorders. Research aims of the CRE include: (i) identification of new gene pathways leading to child speech and language disorders, (ii) conducting genotype-speech and language phenotype association studies for rare genetic syndromes and (iii) elucidating the neurobiology of speech and language disorders using quantitative brain imaging techniques.
This work is undertaken in collaboration with leading Australian and international scientists. Collaborators include: Prof. Ingrid Scheffer (child neurologist), Dr. Michael Hildebrand (molecular geneticist) at the Epilepsy Research Centre and University of Melbourne; Dr. Frederique Liegeois (developmental neuroscientist) at the University College London Institute of Child Health; Prof. Melanie Bahlo (bioinformatician) at the Walter and Eliza Hall Institutes; Prof. Alan Connelly (MR physicist and neuroimaging data acquisition and analysis expert) at the Florey Neuroscience and Mental Health Institutes; Prof. David Amor (clinical geneticist) at the University of Melbourne and Victorian Clinical Genetics Service; Prof. Simon Fisher (biologist) of the Max Planck Institute for Psycholinguistics, Nijmegen, co-founder of FOXP2; Dr. David Koolen (clinical geneticist), Radboud Medical Centre, Nijmegen, co-founder of Koolen de Vries Syndrome; and Dr. Evelina Federenko (cognitive neuroscient) at Harvard and MIT Boston.
- Understanding the brain basis of language development
- Elucidating the neural pathways and genetic basis of speech
Morgan A, Ttofari Eecen K, Pezic A, Brommeyer K, Mei C, Eadie P, Reilly S, Dodd B.
J Pediatr. 2017 Jun;185:200-204.e1. Who to Refer for Speech Therapy at 4 Years of Age Versus Who to "Watch and Wait"?
Turner SJ, Brown A, Arpone M, Anderson V, Morgan AT*, Scheffer IE*. Dysarthria and broader motor speech deficits in Dravet syndrome. Neurology. 2017 Feb 21;88(8):743-749. *Joint senior.
Brignell A, Williams K, Prior M, Donath S, Reilly S, Bavin EL, Eadie P, Morgan AT. Parent-reported patterns of loss and gain in communication in 1- to 2-year-old children are not unique to autism spectrum disorder. Autism. 2017 Apr;21(3):344-356.
Morgan A, Fisher SE, Scheffer I, Hildebrand M. FOXP2-Related Speech and Language Disorders.
In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. 2016 Jun 23 [updated 2017 Feb 2].
Sanchez K, Spittle AJ, Slattery JM, Morgan AT. Oromotor Feeding in Children Born Before 30 Weeks' Gestation and Term-Born Peers at 12 Months' Corrected Age. J Pediatr. 2016 Nov;178:113-118.e1.
Liégeois FJ, Hildebrand MS, Bonthrone A, Turner SJ, Scheffer IE, Bahlo M, Connelly A, Morgan AT. Early neuroimaging markers of FOXP2 intragenic deltion. Sci Rep. 2016 Oct 13;6:35192.
Fedorenko E,* Morgan A,* Murray E, Cardinaux A, Mei C, Tager-Flusberg H, Fisher SE, Kanwisher N. A highly penetrant form of childhood apraxia of speech due to deletion of 16p11.2. Eur J Hum Genet. 2016 Feb;24(2):310. *Authors contributed equally.
Turner SJ, Mayes AK, Verhoeven A, Mandelstam SA, Morgan AT,* Scheffer IE.* GRIN2A: an aptly named gene for speech dysfunction.Neurology. 2015 Feb 10;84(6):586-93. Joint senior.
Turner SJ, Morgan AT, Perez ER, Scheffer IE. New genes for focal epilepsies with speech and language disorders. Curr Neurol Neurosci Rep. 2015 Jun;15(6):35.
Liégeois FJ, Butler J, Morgan AT, Clayden JD, Clark CA. Anatomy and lateralization of the human corticobulbar tracts: an fMRI-guided tractography study. Brain Struct Funct. 2016 Jul;221(6):3337-45.
Mei C, Reilly S, Reddihough D, Mensah F, Pennington L, Morgan A. Language outcomes of children with cerebral palsy aged 5 years and 6 years: a population-based study. Dev Med Child Neurol. 2016 Jun;58(6):605-11.
Reilly S, McKean C, Morgan A, Wake M. (2015) Common Developmental Language and Speech Impairments. British Medical Journal; 350:h2318.
Morgan AT, Mei C, Da Costa A, Fifer J, Lederer D, Benoit V, McMillin M, Buckingham KJ, Bamshad MJ, Pope K, White SM. (2015) Speech and language in a genotyped cohort of individuals with Kabuki syndrome. American Journal of Medical Genetics Part A. [Epub ahead of print].
Lum JA, Conti-Ramsden G, Morgan AT, Ullman MT. (2014). Procedural learning deficits in specific language impairment (SLI): A meta-analysis of serial reaction time task performance Cortex, E-pub Nov 8.
Turner S, Hildebrand M, Block S, Damiano J, Fahey M, Reilly S, Bahlo M, Scheffer I, Morgan A. (2013). Small intragenic deletion of FOXP2 associated with childhood apraxia of speech and dysarthria. American Journal of Medical Genetics Part A, 161(9):2321-6.
Morgan AT, Masterton R, Pigdon L, Connelly A, Liegeois F. (2013). FMRI of chronic dysarthric speech after childhood brain injury: limited efficiency of a compensatory network. Brain, 136(Pt2):646-57.
Liegeois F, Tournier J-D, Pigdon L, Connelly A, Morgan AT. (2013). Corticobulbar tract changes as predictors for dysarthria in childhood ?brain injury. Neurology, 80(10):926-32.
- NHMRC Centre of Research Excellence (in Speech and Language Neurobiology)
- NHMRC Project grant (Genetics of child speech disorder)
- The Waterloo Foundation UK
- Simons Variation in Individuals Project US
- Humboldt Foundation Germany
- March of Dimes Foundation US
Recent past funding as Chief Investigator
- Australian Research Council Discovery grant
- NHMRC Centre of Research Excellence (in Child Language)
- NHMRC Centre of Research Excellence (in Psychosocial Rehabilitation after Traumatic Brain Injury)